European Parliament: how can innovative medtech help in chronic diseases
This article was originally published in Clinica
MEPs Kathleen van Brempt (BE, S&D) and Miroslav Mikolasik (EPP-ED) are due to co-host a meeting next month that will examine, among other matters, how to eliminate EU barriers to the introduction of innovative medical technology for treating chronic disease.
You may also be interested in...
Those marketing products covered under the EU’s MDR and IVD Regulations have plenty of reading this month to help them prepare. More details have also emerged about the UK’s regulatory future.
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.